Related Experiment Video
Updated: Aug 2, 2025

12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
12.5K
Case report: Primary pleural giant extraskeletal Ewing sarcoma in a child
Yang Wu1, Chao-Bang Xie1, Qiong Huang2
1Department of Radiology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Frontiers in Oncology
|April 17, 2023
Summary
This case study highlights a rare instance of primary extraskeletal Ewing sarcoma (EES) in an 11-year-old boy presenting as shoulder pain. Despite chemotherapy, the pleural mass showed no shrinkage, indicating treatment resistance.
Area of Science:
- Oncology
- Pediatric Oncology
- Radiology
Background:
- Primary extraskeletal Ewing sarcoma (EES) is a rare small round cell malignancy, accounting for less than 1% of all sarcomas.
- EES typically occurs in the trunk and lower limbs, with pleural involvement being exceptionally rare and prone to misdiagnosis.
Observation:
- An 11-year-old boy presented with a 6-month history of unexplained left shoulder pain, chest wall tenderness, and limited shoulder mobility.
- Imaging revealed an irregular left thoracic soft tissue mass with pleural and adjacent first rib bone destruction.
- A CT-guided biopsy confirmed extraskeletal Ewing sarcoma.
Findings:
- The patient received alternating cycles of vincristine, doxorubicin, and cyclophosphamide (VDC) and isocyclophosphamide and etoposide (IE) chemotherapy.
- Clinical improvement and pain relief were observed after five chemotherapy cycles.
- However, repeat MRI demonstrated no reduction in the size of the pleural mass, suggesting treatment resistance.
Implications:
- This case underscores the diagnostic challenges of rare extraskeletal Ewing sarcoma presentations.
- The observed lack of tumor response to standard chemotherapy highlights the need for further research into alternative or novel therapeutic strategies for refractory EES.
- Early and accurate diagnosis through advanced imaging and biopsy is crucial for appropriate management of this rare pediatric malignancy.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
Pleural Effusion I: Introduction
1.4K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.4K
Pleural Effusion II: Symptoms and Management
226
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
226

